RFK Jr.'s peptide push could become next wellness boom
Summary
Health Secretary Robert F. Kennedy Jr. is pushing to reduce federal rules on peptides, which could boost companies offering these products. Peptides are popular for fitness and anti-aging, but there is little proof they work well in humans and some doctors warn about health risks.Key Facts
- Peptides are short chains of amino acids used by some people for injury healing, inflammation, and anti-aging.
- The FDA will hold a meeting in July to consider allowing compounding pharmacies to produce certain peptides.
- Currently, Biden administration policy bans compounding pharmacies from making these peptides.
- Some peptides, like BPC-157 from human gastric juice, are promoted based on animal studies, but lack human trial evidence.
- Supporters say peptides have high potential and could create a large market worth up to $180 billion in five years.
- Telehealth companies like Hims & Hers could benefit, already preparing to produce and sell peptides.
- Doctors warn peptides may increase cancer risks and have unknown effects when combined with other drugs.
- There is debate over regulating peptides as supplements versus full drug approval processes.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.